Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitrakvi, Daurismo Approvals Put US FDA On Brink Of Another Record

Executive Summary

New oncologics bring CDER’s novel agent approvals count to 53 for the year.
Advertisement

Related Content

Keeping Track: US FDA Enters Year's Final Stretch With Tsunami Of Novel Approvals
More Good News For AML As Pfizer And AbbVie/Roche Drugs Get FDA Okay
US FDA Blows Past Novel Approvals Record On Way To Unprecedented Year For New Drugs
Keeping Track: Pre-Independence Day Fireworks Crackle At US FDA With Burst Of Approvals And Filings
Loxo Edges Closer To Commercial Market With Larotrectinib, But Diagnostic Challenge Persists
Keeping Track: Submissions Galore, Blincyto Supplemental Approval, And Priority Review For Opdivo/Yervoy Combo
US FDA Outlines Streamlined Development Path For Targeted Therapies
Biomarker-Led Claim Is Small Step For Merck's Keytruda, Giant Leap For Cancer Indications

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel